ERS Genomics

ERS Genomics Licenses CRISPR-Cas9 Patents to Crown Bioscience

ERS was founded to provide access to CRISPR-Cas9 patents held by Emmanuelle Charpentier, who shares the IP with Jennifer Doudna, UC, and the University of Vienna.

ERS Genomics Licenses CRISPR-Cas9 IP to Cosmo Bio

ERS was founded to provide access to CRISPR-Cas9 patents stemming from research conducted at the University of California and the University of Vienna.

In Brief This Week: 908 Devices, Natera, PerkinElmer, Hologic, Hamilton, BioFluidiX, More

News items for the week of Nov. 14, 2022

ERS Genomics Licenses CRISPR/Cas9 IP to Lepton Pharmaceuticals

Lepton, based in Israel, is developing a technology that engineers microRNAs to improve the efficiency and longevity of cells used in cell-based cancer immunotherapies.

ERS Genomics Licenses CRISPR Tech to Swiss Firm Cytosurge

ETH Zurich spinout Cytosurge develops single-cell research solutions and offers a CRISPR-based cell line engineering service.

May 31, 2022

European Patent Office Upholds ERS Genomics-Held CRISPR Patent

Apr 26, 2022

ERS Genomics Licenses CRISPR-Cas9 IP to Sumitomo Pharma

Apr 7, 2022

ERS Genomics Licenses CRISPR IP to Central Institute for Experimental Animals

Feb 4, 2022

People in the News: New Appointments at Centogene, Allelica, ERS Genomics, More

Aug 17, 2021

ERS Genomics Licenses CRISPR-Cas9 Portfolio to Cellular Engineering Technologies

Jul 27, 2021

ERS Genomics Licenses CRISPR IP to Japan SLC

Jun 7, 2021

ERS Genomics Licenses CRISPR IP to GenOway

May 12, 2021

ERS Genomics Licenses CRISPR Patents to GenScript Biotech

Apr 19, 2021

ERS Genomics Licenses CRISPR Patents to Nuvisan

Mar 10, 2021

ERS Genomics Licenses CRISPR Patents to Setsuro Tech

Mar 5, 2021

People in the News: New Appointments at Precipio, ERS Genomics, Omniome, PierianDx, More

Mar 3, 2021

ERS Genomics Licenses CRISPR Patents to Otsuka Pharmaceutical

Feb 23, 2021

ERS Genomics Licenses CRISPR Patents to Korean Biotech Firm G+FLAS Life Sciences

Feb 16, 2021

ERS Genomics Licenses CRISPR Patents to CRO ZeClinics

Dec 1, 2020

ERS Genomics Licenses CRISPR Patents to German Startup Vivlion

Oct 14, 2020

ERS Genomics, FASMAC Sign Deal to Commercialize CRISPR-Cas9 Research Reagents in Japan

Sep 15, 2020

ERS Genomics, Applied StemCell Ink Commercialization Agreement for CRISPR Services, Reagents

Sep 11, 2020

Patent Board Rules Broad Institute First With Functioning CRISPR System in Eukaryotic Cells

Apr 2, 2020

ERS Genomics Licenses CRISPR-Cas9 Patents to Axxam

Feb 11, 2020

ERS Genomics Licenses CRISPR-Cas9 Patents to Aelian Biotechnology

Breaking News

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.